Daniele Scartoni1, Dante Amelio2, Pierpaolo Palumbo3, Irene Giacomelli2, Maurizio Amichetti2. 1. Proton Therapy Center-Azienda Provinciale per i Servizi Sanitari, via al Desert 14, 38123, Trento, Italy. daniele.scartoni@apss.tn.it. 2. Proton Therapy Center-Azienda Provinciale per i Servizi Sanitari, via al Desert 14, 38123, Trento, Italy. 3. Department of Electrical, Electronic, and Information Engineering "Guglielmo Marconi" (DEI), University of Bologna, Bologna, Italy.
Abstract
PURPOSE: Proton therapy could minimize the risk of side effects and, therefore, reduce the possible detrimental effect on health-related quality of life (HRQOL) of re-irradiation. The aim of this study was to determine the effect of re-irradiation with active scanning proton therapy on recurrent glioblastoma (GBM) in terms of HRQOL scored by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-C30 and EORTC Quality of Life Questionnaire Brain Cancer Module (QLQ-BN20). METHODS: Thirty-three patients with recurrent GBM were re-irradiated with active scanning proton therapy. Subscales within the EORTC QLQ-C30 include five functional scales, six single-item scales, and global QoL. The BN20 assessed visual disorders, motor function, communication deficit, various disease symptoms, treatment, toxicity, and future uncertainty. The patients completed the questionnaires before starting proton therapy, the last day of proton therapy, and at every follow-up visit until progression of disease. RESULTS: The treatment was associated with improvement or stability in most of the preselected HRQOL domains. Global health improved over time with a maximum difference of six points between baseline and 3-months follow-up. Social functioning and motor dysfunction improved over time with a maximum difference of eight and two points, respectively. We showed a non-significant decrease in cognitive and emotional functioning. Fatigue remained stable during the analysis such as the other preselected domains. CONCLUSIONS: Re-irradiation with proton therapy is a safe and effective treatment in patients with recurrent glioblastoma. Proton therapy does not negatively effect on HRQOL, but rather it seems to preserve HRQOL until the time of disease progression.
PURPOSE: Proton therapy could minimize the risk of side effects and, therefore, reduce the possible detrimental effect on health-related quality of life (HRQOL) of re-irradiation. The aim of this study was to determine the effect of re-irradiation with active scanning proton therapy on recurrent glioblastoma (GBM) in terms of HRQOL scored by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-C30 and EORTC Quality of Life Questionnaire Brain Cancer Module (QLQ-BN20). METHODS: Thirty-three patients with recurrent GBM were re-irradiated with active scanning proton therapy. Subscales within the EORTC QLQ-C30 include five functional scales, six single-item scales, and global QoL. The BN20 assessed visual disorders, motor function, communication deficit, various disease symptoms, treatment, toxicity, and future uncertainty. The patients completed the questionnaires before starting proton therapy, the last day of proton therapy, and at every follow-up visit until progression of disease. RESULTS: The treatment was associated with improvement or stability in most of the preselected HRQOL domains. Global health improved over time with a maximum difference of six points between baseline and 3-months follow-up. Social functioning and motor dysfunction improved over time with a maximum difference of eight and two points, respectively. We showed a non-significant decrease in cognitive and emotional functioning. Fatigue remained stable during the analysis such as the other preselected domains. CONCLUSIONS: Re-irradiation with proton therapy is a safe and effective treatment in patients with recurrent glioblastoma. Proton therapy does not negatively effect on HRQOL, but rather it seems to preserve HRQOL until the time of disease progression.
Entities:
Keywords:
Proton therapy; Quality of life; Re-irradiation; Recurrence glioblastoma
Authors: F S Lautenschlaeger; R Dumke; M Schymalla; H Hauswald; B Carl; M Stein; U Keber; A Jensen; R Engenhart-Cabillic; F Eberle Journal: Strahlenther Onkol Date: 2021-09-14 Impact factor: 4.033
Authors: Joshua D Palmer; Gordon Chavez; Wesley Furnback; Po-Ya Chuang; Bruce Wang; Christina Proescholdt; Chao-Hsiun Tang Journal: Front Oncol Date: 2021-12-02 Impact factor: 6.244
Authors: Maria Chiara Lo Greco; Roberto Milazzotto; Rocco Luca Emanuele Liardo; Grazia Acquaviva; Madalina La Rocca; Roberto Altieri; Francesco Certo; Giuseppe Maria Barbagallo; Antonio Basile; Pietro Valerio Foti; Stefano Palmucci; Stefano Pergolizzi; Antonio Pontoriero; Corrado Spatola Journal: Brain Sci Date: 2022-03-22